Despite UK High Court setback for Pfizer, Arrow declarations remain a valuable litigation tool
The latest judgment is one of only a few to provide an indication of when the courts will grant the pre-emptive litigation defence remedy, which was issued for the first time in 2017
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.